---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-007906"
form_type: "8-K"
ticker: "CDT"
cik: "0001896212"
company_name: "CDT Equity Inc."
filed_at: "2026-02-24T23:59:59+00:00"
generated_at: "2026-05-16T00:54:10.455514+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# CDT Equity acquires 20% of Sarborg for stock, warrants, deferred $8M cash

## Summary
- Acquired 1,020 Sarborg shares (~20% stake) in exchange for 598,006 shares + pre-funded warrants for 109,978,918 shares at $0.0001 exercise price.
- Agreed to pay Sarborg $8M cash, deferred until CDT raises ≥$20M via ATM program.
- Issued 199,734 shares to NJS Foresight ($150k retainer) and 341,702 shares to Thesprogen ($245k retainer) for consulting extensions.
- Issued 130,000 unregistered shares to Maxim Partners for investment banking services.
- Directors Andrew Regan and Chele Farley have ties to Sarborg; Farley received 10,533 shares + 1,940,804 warrant shares in the transaction.

## SEC filing metadata
- accession: 0001493152-26-007906
- form_type: 8-K
- ticker: CDT
- cik: 0001896212
- company_name: CDT Equity Inc.
- filed_at: 2026-02-24T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1896212/000149315226007906/0001493152-26-007906-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1896212/000149315226007906/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-007906
- JSON: https://secwatch.observer/filing/0001493152-26-007906.json
- Plain text: https://secwatch.observer/filing/0001493152-26-007906.txt

## Source-grounded claims
- claim_id: 43ff9e212ab940578d879f41980c2ec2e4901cf3
  claim: CDT Equity Inc. amended NJS Addendum with NJS Foresight Bio Advisory, LLC valued at $150,000 (effective 2026-02-23).
  evidence_excerpt: On February 23, 2026 (the “ NJS Effective Date ”), the Company and NJS entered into Addendum No. 1 to the NJS Agreement (the “ NJS Addendum ”) to extend the term of the NJS Agreement an additional twelve months from its initial termination date, December 29, 2026, to December 29, 2027, unless terminated earlier in accordance with its terms.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1896212/000149315226007906/0001493152-26-007906-index.htm
- claim_id: 6d22528451f0e89f9362a7afcfc8ec4d2bd4f197
  claim: CDT Equity Inc. entered into Securities Purchase Agreement with all of the stockholders of Sarborg Limited (effective 2026-02-19).
  evidence_excerpt: On February 19, 2026, CDT Equity Inc., a Delaware corporation (the “ Company ”), entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with all of the stockholders (collectively, the “ Investors ”) of Sarborg Limited, a Cayman Islands Company (“ Sarborg ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1896212/000149315226007906/0001493152-26-007906-index.htm
- claim_id: ec86a6e550cab5eeca773282032d3312751e4c14
  claim: CDT Equity Inc. amended Thesprogen Addendum with Thesprogen, PC valued at $245,000 (effective 2026-02-24).
  evidence_excerpt: On February 24, 2026 (the “ Thesprogen Effective Date ”), the Company and Thesprogen entered into Addendum No. 1 to the Thesprogen Agreement (the “ Thesprogen Addendum ”) to extend the term of the Thesprogen Agreement an additional twelve months from its initial termination date, June 28, 2026, to June 28, 2027, unless terminated in accordance with its terms.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1896212/000149315226007906/0001493152-26-007906-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.